Mother took Evrysdi for SMA before birth; baby later received Zolgensma. Dr. Richard Finkel at St. Jude led study showing no ...
Keymed Biosciences is a prime example of a young Chinese biotech churning out pipeline candidates ripe for out-licensing to ...
UnitedHealthcare offers voluntary buyouts to 30,000 employees due to low attrition and digital shift, COO Michael Baker tells ...
Charles River Labs beats Q4 estimates, Theratechnologies resumes Egrifta SV distribution, FDA greenlights BCG alternative, ...
The Trump administration's respective nominees for CMS administrator and NIH director, Mehmet Oz and Jay Bhattacharya, ...
The European Union’s proposed ban of so-called “forever chemicals” is expected to become law this year, and investors are ...
A French biotech focused on developing genetic medicines for neurological conditions has secured €27 million in a Series B ...
BridgeBio revealed Thursday that prescriptions for its recently approved rare heart disease drug Attruby substantially beat ...
A meet­ing of CDC vac­cine ad­vi­sors has been post­poned, ac­cord­ing to a se­nior HHS of­fi­cial. “The ACIP meet­ing will be post­poned to ac­com­mo­date pub­lic com­ment … ...
HHS Secretary RFK Jr. announces vaccine schedule review despite prior pledges not to, contradicting promises made during ...
Hims & Hers bought an at-home lab test­ing com­pa­ny as it branch­es out in­to oth­er clin­i­cal ar­eas be­yond its re­cent ...
Illumina to cut 96 San Diego jobs by April 14; Incyte partners with Genesis on AI for $30M upfront; 2048 Ventures plans $75M fund; Atai Life Sciences raises $63.2M ...